Pulmonary hypertension in interstitial lung disease: Prevalence, prognosis and 6 min walk test

Respiratory Medicine

Volumn 106, Issue 6, 2012, Pages 875-882

  Andersen, Charlotte U ^a   Mellemkjær, Søren ^b   Hilberg, Ole ^b   Nielsen Kudsk, Jens Erik ^b   Simonsen, Ulf ^a   Bendstrup, Elisabeth ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Exercise capacity; Interstitial lung disease; Lung fibrosis; Prognosis; Pulmonary circulation; Pulmonary hypertension

Indexed keywords

6 MIN WALK TEST; ADULT; ARTICLE; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART CATHETERIZATION; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; WALKING;

AGED; DENMARK; EXERCISE TEST; FEMALE; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RESPIRATORY MECHANICS;

EID: 84859789454     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.02.015     Document Type: Article

References (34)

1. Goto K, Arai M, Watanabe A, Hasegawa A, et al. Utility of echocardiography versus BNP level for the prediction of pulmonary arterial pressure in patients with pulmonary arterial hypertension. Int Heart J 2010;5:343-7.
2. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;5:735-40. (Pubitemid 36801751)
3. Nathan SD, Shlobin OA, Barnett SD, Saggar R, et al. Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med 2008;9:1305-10.
4. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006;3:746-52.
5. Shorr AF, Wainright JL, Cors CS, Lettieri CJ, et al. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 2007;4:715-21. (Pubitemid 351194832)
6. Handa T, Nagai S, Miki S, Fushimi Y, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006;5:1246-52.
7. Shorr AF, Helman DL, Davies DB, Nathan SD. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005;5:783-8. (Pubitemid 40667674)
8. Chang B, Wigley FM, White B, Wise RA. Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol 2003;11:2398-405. (Pubitemid 37413900)
9. Launay D, Mouthon L, Hachulla E, Pagnoux C, et al. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. J Rheumatol 2007;5:1005-11. (Pubitemid 46774846)
10. Le PJ, Humbert M, Mouthon L, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2010;12:1285-93.
11. Dempsey OJ, Kerr KM, Remmen H, Denison AR. How to investigate a patient with suspected interstitial lung disease. BMJ 2010:c2843.
12. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus classification of the idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;2:277-304.
13. Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006;9:1034-41. (Pubitemid 44684453)
14. Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol 2000;1: 176-82. (Pubitemid 30061277)
15. Rosenberg E. The 1995 update of recommendations for a standard technique for measuring the single-breath carbon monoxide diffusing capacity (transfer factor). Am J Respir Crit Care Med 1996;3(1):827-8.
16. Cotes JE, Chinn DJ, Quanjer PH, Roca J, et al. Standardization of the measurement of transfer factor (diffusing capacity). Report working party standardization of lung function tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993;(Suppl.): 41-52.
17. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;1:111-7.
18. Lama VN, Flaherty KR, Toews GB, Colby TV, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;9: 1084-90. (Pubitemid 37338937)
19. Du Bois RM, Weycker D, Albera C, Bradford WZ, et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med 2011;9:1231-7.
20. Farkas L, Gauldie J, Voelkel NF, Kolb M. Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors. Am J Respir Cell Mol Biol 2011; 1:1-15.
21. Polomis D, Runo JR, Meyer KC. Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med 2008;5:462-9.
22. Hemnes AR, Zaiman A, Champion HC. PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation. Am J Physiol Lung Cell Mol Physiol 2008;1:L24-33. (Pubitemid 351380315)
23. Todd NW, Lavania S, Park MH, Iacono AT, et al. Variable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia. J Heart Lung Transplant 2010;2:188-94.
24. Whelan TP, Dunitz JM, Kelly RF, Edwards LB, et al. Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis. J Heart Lung Transplant 2005;9:1269-74. (Pubitemid 41247809)
25. Gagermeier J, Dauber J, Yousem S, Gibson K, et al. Abnormal vascular phenotypes in patients with idiopathic pulmonary fibrosis and secondary pulmonary hypertension. Chest 2005; (Suppl. 6):601S. (Pubitemid 43054149)
26. Handa T, Nagai S, Miki S, Ueda S, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with interstitial pneumonias: comparison between idiopathic and collagen vascular disease associated interstitial pneumonias. Intern Med 2007;12:831-7. (Pubitemid 47263380)
27. Nathan SD, Shlobin OA, Ahmad S, Urbanek S, et al. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007;3:657-63. (Pubitemid 46446854)
28. Hamada K, Nagai S, Tanaka S, Handa T, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007;3:650-6. (Pubitemid 46446853)
29. Leuchte HH, Neurohr C, Baumgartner R, Holzapfel M, et al. Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 2004; 4:360-5. (Pubitemid 39214607)
30. Modrykamien AM, Gudavalli R, McCarthy K, Parambil J. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis. Respir Care 2010;5:584-8.
31. Swigris JJ, Olson AL, Shlobin OA, Ahmad S, et al. Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respirology 2011;3:439-45.
32. Zisman DA, Karlamangla AS, Ross DJ, Keane MP, et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007;3:773-9.
33. Boutou AK, Pitsiou GG, Trigonis I, Papakosta D, et al. Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension. Respirology 2011;3:451-8.
34. Glaser S, Noga O, Koch B, Opitz CF, et al. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med 2009;2:317-24.